Vzácná onemocnění 2

28 | www.solen.cz Literatura 1. Klekamp J, Samii M. Syringomyelia. Diagnosis and Treatment. Springer 2002: 27–34. 2. Elster AD, Chen MY. Chiari malformation I: Clinical and radiological reappraisal. Radiology 1992; 183: 347–353. 3. Gardner WJ. Hydrodynamic mechanisms of syringomyelia: its relationship to myelocele. J Neurol Neurosurg Psychiatry 1965; 28: 247–259. 4. Williams B. On the pathogenesis of syringomyelia: a review. J R Soc Med 1980; 73: 798–806. 5. Oldfield EH, Muraszko K, Shawker TH, Patronas NJ. Pathophysiology of syringomyelia associated with Chiari I malformation of the cerebellar tonsils. Implications for diagnosis and treatment. J Neurosurg 1994; 80: 3–15. 6. Bonfield CM, Levi AD, Arnold PM, Okonkwo DO. Surgical management of post-traumatic syringomyelia. Spine (Phila Pa 1976) 2010; 35: 245–258. 7. Abel TJ, Howard MA 3 rd , Menezes A. Syringomyelia and spinal arachnoiditis resulting from aneurysmal subarachnoid hemorr- hage: Report of two cases and review of the literature. J Craniovertebr Junction Spine 2014; 5: 47–51. 8. Rossier AB, Foo D, Shillito J, Dyro FM. Posttraumatic cervical syringomyelia. Incidence, clinical presentation, electrophysiolo- gical studies, syrinx protein and results of conservative and operative treatment. Brain 1985; 108: 439–461. 9. Klekamp J, Samii M. Syringomyelia. Diagnosis and Treatment. Springer 2002: 110–157. 10. Piatt JH Jr. Progressive syringomyelia controlled by treatment of associated hydrocephalus in an infant with birth injury. Case report. J Neurosurg 2003; 98: 106–116. 11. Chandy MJ, Babu S. Management of intramedullary spinal cord tumours: review of 68 patients. Neurol India 1999; 47: 224–228. 12. Lonser RR, Weil RJ, Wanebo JE, DeVroom HL, Oldfield EH. Surgical management of spinal cord hemangioblastomas in pa- tients with von Hippel-Lindau disease. J Neurosurg 2005; 103: 198–202. 13. Nevšímalová S, Ambler Z. Vývojové a kongenitální abnormity. In: Bednařík J, Ambler Z, Růžička a kol: Klinická neurologie. Část speciální II. Triton 2010: 742–748. 14. Sakushima K, Tsuboi S, Yabe I, Hida K, Terae S, Uehara R, Nakano I, Sasaki H. Nationwide survey on the epidemiology of sy- ringomyelia in Japan. J Neurol Sci 2012; 313: 147–152. 15. Fernández AA, Guerrero AI, Martínez MI, Vázquez ME, Fernández JB, Chesa i Octavio E, Labrado Jde L, Silva ME, de Ara- oz MF, García-Ramos R, Ribes MG, Gómez C, Valdivia JI, Valbuena RN, Ramón JR. Malformations of the craniocervical junction (Chiari type I and syringomyelia: classification, diagnosis and treatment). BMC Musculoskelet Disord. 2009; 10(Suppl 1): S1. 16. Štětkářová I,KoflerM,LeisAA.Cutaneousandmixednervesilentperiod incervicalsyringomyelia.ClinNeurophysiol2001;112:78–85. 17. Bednařík J. Spondylogenní myelopatie. In: Bednařík J, Ambler Z, Růžička, a kol. Klinická neurologie. Část speciální II. Triton 2010. Pp. 1103–1112 18. Klekamp J, Samii M. Syringomyelia. Diagnosis and Treatment. Springer 2002: 127–136. 19. Štětkářová I. Perorální léčba spasticity. In: Štětkářová I, Ehler E, Jech R (Eds.): Spasticita a její léčba. Maxdorf, 2012. Pp. 59–66 20. Ehler E, Štětkářová I. Botulotoxin v léčbě spasticity. Česk Slov Neurol N 2009; 72: 317–321. 21. Zahavi A, Geertzen JHB, Staal M, Rietman JS. Long term effect (more than five years) of Intrathecal baclofen on impairment, disability and quality of life in patients with severe spasticity of spinal origin. J Neurol Neurosurg Psychiatry 2004; 75: 1553–1557. 22. Štětkářová I, Šroubek J, Vrba I, Peregrin J, Havrdová E. Jednorázové intratékální podání baklofenu a následné zavedení pum- pového systému v léčbě těžké spasticity u osob s roztroušenou sklerózou. Česk Slov Neurol N 2007; 70: 190–195. 23. Montané E, Vallano A, Laporte JR. Oral antispastic drugs in nonprogressive neurologic diseases: a systematic review. Neu- rology 2004; 63: 1357–1363. 24. Telles SC, Alves RC, Chadi G. Periodic limb movements during sleep and restless legs syndrome in patients with ASIA A spi- nal cord injury. J Neurol Sci 2011; 303: 119–123. doc. MUDr. Ivana Štětkářová, CSc. Neurologická klinika 3. LF UK a FNKV Šrobárova 50, 100 34 Praha 10 ivana.stetkarova@fnkv.cz